Scnn1a-flox Mouse
一般名
Scnn1a-flox
製品ID
S-CKO-17705
背景情報
C57BL/6JCya
系統ID
CKOCMP-20276-Scnn1a-B6J-VC
状況
このマウス系統を論文で使用する場合は、「Scnn1a-flox Mouse(カタログ番号S-CKO-17705)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Scnn1a-flox
系統ID
CKOCMP-20276-Scnn1a-B6J-VC
遺伝子名
製品ID
S-CKO-17705
遺伝子別名
ENaC, SCNEA, Scnn1, mENaC
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 6
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000081440
NCBIトランスクリプトID
NM_011324
ターゲット領域
Exon 2
有効領域の大きさ
~0.8 kb
遺伝子研究の概要
Scnn1a, which encodes the α -subunit of the epithelial sodium channel (α -ENaC), plays a crucial role in regulating sodium absorption in epithelial tissues, such as those in the kidney, lung, and colon. This process is essential for maintaining fluid and electrolyte balance, blood pressure regulation, and normal organ function [2,5,6]. Dysregulation of Scnn1a can disrupt these physiological processes, leading to various health issues.
In terms of disease associations, mutations in Scnn1a can cause Liddle syndrome, an autosomal-dominant monogenic disease characterized by early-onset hypertension, hypokalaemia, and metabolic alkalosis [2]. Additionally, Scnn1a has been implicated in several cancers. In ovarian cancer, its overexpression is correlated with poor prognosis and immune cell infiltration, and it may play a role in cell growth, invasion, and migration through regulating epithelial-mesenchymal transformation [1,4]. In pancreatic cancer, Scnn1a overexpression is associated with TP53 mutation and unfavorable prognosis, and it exerts oncogenic functions by accelerating cellular growth and metastasis [3]. In triple-negative breast cancer, high Scnn1a expression is associated with poor prognosis and non-pathological complete response status following neoadjuvant chemotherapy [9]. A novel mutation in Scnn1a has also been found in a patient with autosomal-recessive pseudohypoaldosteronism type 1 [5], and SNPs in Scnn1a may be associated with neonatal respiratory distress syndrome, particularly in term infants [8]. miR-95 promotes osteosarcoma growth by targeting Scnn1a [7].
In conclusion, Scnn1a is vital for maintaining fluid and electrolyte balance through its role in sodium absorption. Its dysregulation, whether through mutation or altered expression, is associated with various diseases, including monogenic hypertension, pseudohypoaldosteronism, neonatal respiratory distress syndrome, and multiple types of cancer. Understanding the function of Scnn1a through genetic models could potentially lead to better diagnostic and therapeutic strategies for these conditions.
References:
1. Lou, Jiayan, Wei, Lingjia, Wang, He. 2022. SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer. In International journal of general medicine, 15, 1743-1763. doi:10.2147/IJGM.S351976. https://pubmed.ncbi.nlm.nih.gov/35221714/
2. Tian, Jiajia, Xiang, Fei, Wang, Liandi, Ma, Li, Fang, Chuwen. 2024. Liddle Syndrome with a SCNN1A Mutation: A Case Report and Literature Review. In Kidney & blood pressure research, 49, 831-838. doi:10.1159/000540522. https://pubmed.ncbi.nlm.nih.gov/39236685/
3. Gao, Feng, Wang, Dan, Liu, Xun, Wang, Huai-Tao, Sun, Shao-Long. 2022. Sodium channel 1 subunit alpha SCNN1A exerts oncogenic function in pancreatic cancer via accelerating cellular growth and metastasis. In Archives of biochemistry and biophysics, 727, 109323. doi:10.1016/j.abb.2022.109323. https://pubmed.ncbi.nlm.nih.gov/35714697/
4. Wu, Lan, Ling, Zhong-Hui, Wang, Huan, Wang, Xin-Yan, Gui, Jing. 2019. Upregulation of SCNN1A Promotes Cell Proliferation, Migration, and Predicts Poor Prognosis in Ovarian Cancer Through Regulating Epithelial-Mesenchymal Transformation. In Cancer biotherapy & radiopharmaceuticals, 34, 642-649. doi:10.1089/cbr.2019.2824. https://pubmed.ncbi.nlm.nih.gov/31549859/
5. Huneif, Mohammed Ayed, Alhazmy, Ziyad Hamad, Shoomi, Anas M., Mushiba, Aziza M., AlSaheel, Abdulhamid. 2021. A Novel SCNN1A Variation in a Patient with Autosomal-recessive Pseudohypoaldosteronism Type 1. In Journal of clinical research in pediatric endocrinology, 14, 244-250. doi:10.4274/jcrpe.galenos.2021.2020.0175. https://pubmed.ncbi.nlm.nih.gov/33829730/
6. Serra, Gregorio, Antona, Vincenzo, D'Alessandro, Maria Michela, Verde, Vincenzo, Corsello, Giovanni. 2021. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town. In Italian journal of pediatrics, 47, 138. doi:10.1186/s13052-021-01080-x. https://pubmed.ncbi.nlm.nih.gov/34134742/
7. Geng, Yannan, Zhao, Shaorong, Jia, Yutao, Zhang, Quan, Tian, Rong. 2020. miR‑95 promotes osteosarcoma growth by targeting SCNN1A. In Oncology reports, 43, 1429-1436. doi:10.3892/or.2020.7514. https://pubmed.ncbi.nlm.nih.gov/32323794/
8. Li, Wang, Long, Chen, Renjun, Li, Juan, Ma, Yuan, Shi. 2015. Association of SCNN1A Single Nucleotide Polymorphisms with neonatal respiratory distress syndrome. In Scientific reports, 5, 17317. doi:10.1038/srep17317. https://pubmed.ncbi.nlm.nih.gov/26611714/
9. Jin, Xin, Ge, Yue, Sun, Tongjun, Zhang, Ligong, Qian, Jun. 2025. SCNN1A expression in triple-negative breast cancer: clinical implications for prognosis and neoadjuvant therapy response. In World journal of surgical oncology, 23, 169. doi:10.1186/s12957-025-03698-1. https://pubmed.ncbi.nlm.nih.gov/40287704/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
